Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

AI Pharma Startup METiS Raises $150 Million. IPO In Sight?

Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million The company was incubated by AI pharmaceutical unicorn XtaiPl, whose most recent valuation exceeded $2.05 billion By Molly Wen

Benzinga

Intel Whale Trades Spotted

Someone with a lot of money to spend has taken a bullish stance on Intel (NASDAQ:INTC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Earnings Preview For Valens Co

Valens Co (NASDAQ:VLNS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Valens Co will report an earnings per share (EPS) of $-0.22.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Check Out What Whales Are Doing With GOOGL

Someone with a lot of money to spend has taken a bearish stance on Alphabet (NASDAQ:GOOGL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Theratechnologies Earnings Preview

Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Theratechnologies will report an earnings per share (EPS) of $-0.07.

Benzinga

Earnings Preview For Dolphin Entertainment

Dolphin Entertainment (NASDAQ:DLPN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Dolphin Entertainment will report an earnings per share (EPS) of $-0.02.

Benzinga

Fastenal Earnings Preview

Fastenal (NASDAQ:FAST) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Fastenal will report an earnings per share (EPS) of $0.44.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Hooker Furniture's Earnings: A Preview

Hooker Furniture (NASDAQ:HOFT) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Hooker Furniture will report an earnings per share (EPS) of $0.10.

Benzinga

Akerna Flash Predicts 420 To Bring In Over $130M In Legal Cannabis Sales; Will It Be The Largest Sales Day Ever?

Akerna (NASDAQ: KERN) predicts that U.S.

Benzinga

BofA Says Paramount+ Momentum Continues Into 1Q

Paramount Global’s (NASDAQ: PARA) first-quarter results are likely to reflect continued momentum and investments in streaming, according to BofA Securities.

Benzinga

Texas-Made Tesla Model Y Price And Range Leaked

Tesla Inc (NASDAQ: TSLA) debuted its Giga Texas factory in Austin with the Cyber Rodeo, marking the production of its new Texas-made Model Y vehicles.

Benzinga

Why Nvidia Looks Set To Bounce As Market Rebounds

NVIDIA Corporation (NASDAQ: NVDA) continued its nine-day descent on Monday, gapping down 3.9% to start the session and closing the trading day an additional 1.34% lower.

Benzinga

Overview Of Value Stocks In The Consumer Cyclical Sector

What are Value Stocks?

Benzinga

5 Value Stocks In The Technology Sector

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With CRWD

Someone with a lot of money to spend has taken a bearish stance on CrowdStrike Holdings (NASDAQ:CRWD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Robot-Run ETF Known For Tesla, Apple Bets Cut Out Chipmakers In March And Bet On This Retail Giant Instead

Tech stocks have fallen out of favor amid the current macroeconomic and geopolitical turmoil, so it doesn't come as a surprise that an AI-powered exchange-traded fund, popular for its bets on EV leader Tesla, Inc. (NASDAQ: TSLA), has opted to liquidate out of high-profile chipmakers in March.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022

Upgrades

Benzinga

Qualcomm Whale Trades For April 12

Someone with a lot of money to spend has taken a bearish stance on Qualcomm (NASDAQ:QCOM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings for BioNTech

Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings:

Benzinga

Disney's Jettisoned LGBTQ Animated Film 'Nimona' Acquired By Netflix

Netflix (NASDAQ: NFLX) has acquired the rights to the unfinished animated film adaptation of ND Stevenson’s best-selling graphic novel “Nimona” which was canceled by the Walt Disney Co. (NYSE:

Benzinga

Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors

Repare Therapeutics Inc (NASDAQ:RPTX) presented updated data from its ongoing Phase 1/2 TRESR trial of RP-3500 for solid tumors with specific synthetic-lethal genomic alterations. The data were featured at the AACR Annual Meeting included monotherapy Phase 1 (Module 1) results from 120 patients. RP-3500 monotherapy appeared to be safe and well-tolerated. Mild to…

Benzinga

Here's Why OrganiGram Shares Are Rising

OrganiGram Holdings Inc (NASDAQ: OGI) shares are trading higher by 8.72% at $1.62 during Tuesday's pre-market session after the company reported better-than-expected second-quarter sales results and said it expects third-quarter sales to be higher than second-quarter 2022.

Benzinga

Lixte Biotech Shares Jumps Over 100% On Promising Preclinical Data From Lead Program In KRAS-Mutant Cancers

LIXTE Biotechnology Holdings Inc (NASDAQ:LIXT) shares are trading higher after the presentation of new data from drug combinations of LIXTE's lead clinical cancer compound, LB-100. Data were shared at the Annual Meeting of the American Association for Cancer Research (AACR). LIXTE's lead clinical compound and protein phosphatase 2A (PP2A) inhibitor, LB-100, further activates…

Benzinga

Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the

Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 723 724 725 726

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.